Inactive Instrument
Midatech Pharma PLC Share Price Nasdaq
Stocks
US59564R1041
Biotechnology & Medical Research
| Market Cap | 525K 694K 610K 575K 982K 66.62M 990K 6.89M 2.65M 33.99M 2.6M 2.55M 110M | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 525K 694K 610K 575K 982K 66.62M 990K 6.89M 2.65M 33.99M 2.6M 2.55M 110M | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
0.04% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.38% |
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Stamp
CEO | Chief Executive Officer | 65 | 30/03/2020 |
Fiona Sharp
DFI | Director of Finance/CFO | 58 | 04/01/2026 |
Noreen Bhatti
CTO | Chief Tech/Sci/R&D Officer | - | 30/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Sijmen de Vries
BRD | Director/Board Member | 67 | 12/11/2014 |
Simon Turton
BRD | Director/Board Member | 59 | 11/12/2014 |
Stephen Stamp
BRD | Director/Board Member | 65 | 08/09/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.38% | -20.98% | - | - | 709K | |
| -3.30% | +2.97% | +54.99% | +104.15% | 74.18B | |
| -0.12% | -1.63% | +33.14% | +74.86% | 59.55B | |
| +2.71% | -0.84% | -16.39% | +364.46% | 25.84B | |
| +0.81% | +3.58% | +1.01% | -5.14% | 24.73B | |
| -1.05% | +2.58% | +24.27% | -10.32% | 20.87B | |
| -1.70% | -4.15% | +147.82% | +325.69% | 15.32B | |
| +2.15% | +2.06% | +45.57% | +169.79% | 14.06B | |
| -0.43% | -5.32% | -14.46% | +775.94% | 13.12B | |
| +0.04% | -3.00% | +15.76% | +234.69% | 11.85B | |
| Average | -0.05% | -0.80% | +32.41% | +226.01% | 28.84B | |
| Weighted average by Cap. | -0.71% | -0.22% | +34.92% | +160.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
-
